The U.S. Food and Drug Administration rejected pleconaril in 2002 due to the side effects. The most commonly reported side effects were mild to moderate headache, diarrhea, and nausea.<ref name="Pleconaril study results in double blind trials">{{cite journal|last=Hayden|first=F.G.|last2=Herrington|first2=D.T.|last3=Coats|first3=T.L.|last4=Kim|first4=K.|last5=Cooper|first5=E.C.|last6=Villano|first6=S.A.|last7=Liu|first7=S.|last8=Hudson|first8=S.|last9=Pevear|first9=D.C.|last10=Collett|first10=M.|last11=McKinlay|first11=M.| department=Pleconaril Respiratory Infection Study, Group|title=Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.|journal=Clinical Infectious Diseases|date=Jun 15, 2003|volume=36|issue=12|pages=1523â€“32|pmid=12802751|doi=10.1086/375069}}</ref>  Some women were having symptoms of spotting in between periods. Menstrual irregularities were reported by 3.5% of the 320 pleconaril treated women using oral contraceptives and by none of the 291 placebo treated women.<ref name="Pleconaril study results in double blind trials" />  In the clinical trial two women became pregnant due to the drug interfering with hormonal birth control. Other patients have described painful nasal inflammation.<ref name="Curing the Common Cold">{{cite web|last=Greenwood|first=Veronique|title=Curing the Common Cold|url=http://www.scientificamerican.com/article.cfm?id=curing-the-common-cold|publisher=Scientific American|accessdate=2013-03-25}}</ref> Another side effect of the Pleconaril drug trials was activation of [[CYP3A|cytochrome P-450 3A enzymes]].

 

